ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $374,000 | +78.1% | 4,020 | +14.2% | 0.04% | +66.7% |
| Q3 2021 | $210,000 | -12.5% | 3,520 | 0.0% | 0.03% | -15.6% |
| Q2 2021 | $240,000 | -1.6% | 3,520 | 0.0% | 0.03% | -11.1% |
| Q1 2021 | $244,000 | -9.6% | 3,520 | 0.0% | 0.04% | -16.3% |
| Q4 2020 | $270,000 | +2.7% | 3,520 | 0.0% | 0.04% | -6.5% |
| Q3 2020 | $263,000 | +18.5% | 3,520 | 0.0% | 0.05% | +9.5% |
| Q2 2020 | $222,000 | +50.0% | 3,520 | 0.0% | 0.04% | +31.2% |
| Q1 2020 | $148,000 | -7.5% | 3,520 | 0.0% | 0.03% | +10.3% |
| Q4 2019 | $160,000 | -0.6% | 3,520 | 0.0% | 0.03% | -9.4% |
| Q3 2019 | $161,000 | -21.8% | 3,520 | 0.0% | 0.03% | -23.8% |
| Q2 2019 | $206,000 | +30.4% | 3,520 | 0.0% | 0.04% | +5.0% |
| Q1 2019 | $158,000 | +16.2% | 3,520 | +0.6% | 0.04% | +8.1% |
| Q4 2018 | $136,000 | -15.5% | 3,500 | 0.0% | 0.04% | -14.0% |
| Q3 2018 | $161,000 | +5.2% | 3,500 | 0.0% | 0.04% | -2.3% |
| Q2 2018 | $153,000 | +23.4% | 3,500 | 0.0% | 0.04% | +18.9% |
| Q1 2018 | $124,000 | -7.5% | 3,500 | 0.0% | 0.04% | -14.0% |
| Q4 2017 | $134,000 | +45.7% | 3,500 | 0.0% | 0.04% | +38.7% |
| Q3 2017 | $92,000 | +43.8% | 3,500 | 0.0% | 0.03% | +24.0% |
| Q2 2017 | $64,000 | – | 3,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |